McDermott DH - Search Results

1

Assessment of cumulative evidence on genetic associations: interim guidelines.

Ioannidis JP, Boffetta P, Little J, O'Brien TR, Uitterlinden AG, Vineis P, Balding DJ, Chokkalingam A, Dolan SM, Flanders WD, Higgins JP, McCarthy MI, McDermott DH, Page GP, Rebbeck TR, Seminara D, Khoury MJ. Ioannidis JP, et al. Among authors: mcdermott dh. Int J Epidemiol. 2008 Feb;37(1):120-32. doi: 10.1093/ije/dym159. Epub 2007 Sep 26. Int J Epidemiol. 2008. PMID: 17898028 Review.

2

Effect of chemokine receptor gene polymorphisms on the response to potent antiretroviral therapy.

O'Brien TR, McDermott DH, Ioannidis JP, Carrington M, Murphy PM, Havlir DV, Richman DD. O'Brien TR, et al. Among authors: mcdermott dh. AIDS. 2000 May 5;14(7):821-6. doi: 10.1097/00002030-200005050-00008. AIDS. 2000. PMID: 10839590 Clinical Trial.

3

Genetic polymorphism in CX3CR1 and risk of HIV disease.

McDermott DH, Colla JS, Kleeberger CA, Plankey M, Rosenberg PS, Smith ED, Zimmerman PA, Combadière C, Leitman SF, Kaslow RA, Goedert JJ, Berger EA, O'Brien TR, Murphy PM. McDermott DH, et al. Science. 2000 Dec 15;290(5499):2031. doi: 10.1126/science.290.5499.2031a. Science. 2000. PMID: 11187812 No abstract available.

4

Chemokine receptor polymorphism and risk of acute rejection in human renal transplantation.

Abdi R, Huong TTB, Sahagun-Ruiz A, Murphy PM, Brenner BM, Milford EL, McDermott DH. Abdi R, et al. Among authors: mcdermott dh. J Am Soc Nephrol. 2002 Mar;13(3):754-758. doi: 10.1681/ASN.V133754. J Am Soc Nephrol. 2002. PMID: 11856781

5

Associations of chemokine system polymorphisms with clinical outcomes and treatment responses of chronic hepatitis C.

Promrat K, McDermott DH, Gonzalez CM, Kleiner DE, Koziol DE, Lessie M, Merrell M, Soza A, Heller T, Ghany M, Park Y, Alter HJ, Hoofnagle JH, Murphy PM, Liang TJ. Promrat K, et al. Among authors: mcdermott dh. Gastroenterology. 2003 Feb;124(2):352-60. doi: 10.1053/gast.2003.50061. Gastroenterology. 2003. PMID: 12557141

6

CCR5: no longer a "good for nothing" gene--chemokine control of West Nile virus infection.

Lim JK, Glass WG, McDermott DH, Murphy PM. Lim JK, et al. Among authors: mcdermott dh. Trends Immunol. 2006 Jul;27(7):308-12. doi: 10.1016/j.it.2006.05.007. Epub 2006 Jun 5. Trends Immunol. 2006. PMID: 16753343 Review.

7

CCR5 promoter polymorphism and HIV-1 disease progression. Multicenter AIDS Cohort Study (MACS).

McDermott DH, Zimmerman PA, Guignard F, Kleeberger CA, Leitman SF, Murphy PM. McDermott DH, et al. Lancet. 1998 Sep 12;352(9131):866-70. doi: 10.1016/s0140-6736(98)04158-0. Lancet. 1998. PMID: 9742978 Free article.

8

Chemokine RANTES promoter polymorphism affects risk of both HIV infection and disease progression in the Multicenter AIDS Cohort Study.

McDermott DH, Beecroft MJ, Kleeberger CA, Al-Sharif FM, Ollier WE, Zimmerman PA, Boatin BA, Leitman SF, Detels R, Hajeer AH, Murphy PM. McDermott DH, et al. AIDS. 2000 Dec 1;14(17):2671-8. doi: 10.1097/00002030-200012010-00006. AIDS. 2000. PMID: 11125885

9

Association between polymorphism in the chemokine receptor CX3CR1 and coronary vascular endothelial dysfunction and atherosclerosis.

McDermott DH, Halcox JP, Schenke WH, Waclawiw MA, Merrell MN, Epstein N, Quyyumi AA, Murphy PM. McDermott DH, et al. Circ Res. 2001 Aug 31;89(5):401-7. doi: 10.1161/hh1701.095642. Circ Res. 2001. PMID: 11532900

10

Chemokines and their receptors in infectious disease.

McDermott DH, Murphy PM. McDermott DH, et al. Springer Semin Immunopathol. 2000;22(4):393-415. doi: 10.1007/s002810000052. Springer Semin Immunopathol. 2000. PMID: 11155443 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

78 results

Search Page